Accredited Spring Health Symposium Offers Latest Information to Healthcare Professionals

Spring Health Symposium, April 28, 2018 - Heartland Cancer Center, Garden City, KSCentral Care Cancer Center is bringing the Spring Health Symposium to Garden City on April 28. The symposium, which is accredited through Menorah Medical Center, will be held at the state-of-the-art Heartland Cancer Center, located at 410 E. Spruce St. Completion of the symposium will provide up to six credits for physicians, physician assistants, APRNs and nurses.

The Spring Health Symposium is designed to provide participants with a well-rounded selection of relevant, applicable and up-to-date topics in healthcare. Eight experts will conduct presentations in their respective fields. The symposium begins with a registration and breakfast at 7 a.m. and ends by 3 p.m. The cost of the symposium is $20 and includes breakfast and lunch.

“Our goal is to offer a healthcare event that is of the highest quality and affordability to professionals across western Kansas,” said Dr. Claudia Perez-Tamayo, President and radiation oncologist for Central Care Cancer Center. “Our symposium focuses on advances in healthcare, which will be available in this region.”

Topics and presenters are: Systemic Management of Breast Cancer: Current & Future Directions,Stephanie Graff, MD, Breast Program Director, Sarah Cannon HCA Midwest Health; Managing Complex Hematologic Disorders in the Community Setting, Suman Kambhampati, MD, Blood Cancer Program Medical Director, Sarah Cannon HCA Midwest Health; Latest Advances & Techniques in Treating Gynecologic Malignancies, K. Shawn LyBarger, DO, Division Director for Gynecologic Oncology, Sarah Cannon HCA Midwest Health Medical Director, Kansas City Institute for Robotics; Hereditary Cancer Predisposition: Updates in Genetic Testing, Lenna Levitch, MS, CGC, LGC, Genetics Program Director, Sarah Cannon HCA Midwest Health; Incorporating Wellness into the Cancer Care Plan, Sami Mansfield, Oncology Wellness and Rehab Director, Sarah Cannon HCA Midwest Health; Advances in Pain Treatment with Focus on Intrathecal Drug Therapy, John Clough, MD, Neurosurgeon, Sarah Cannon HCA Midwest Health; Building a Lung Nodule Program,Ryan Hallenbeck, MBA, Regional Vice President Oncology Services, Sarah Cannon HCA Midwest Health; and Lung Cancer Screening/Pulmonary Nodule Management, Jeffrey Sparacino, DO, Interventional Radiologist, St. Catherine Hospital.

A far-reaching objective of the Spring Health Care Symposium, Perez-Tamayo stated, is to advance healthcare in western Kansas so that patients will continue seeking care in regions where they live. She sees the benefits of keeping patients at home, where they are not burdened with the stresses of travel, attending multiple appointments in unfamiliar locations, and dealing with incomplete patient records when visiting different providers.

“People shouldn’t have to travel far to get quality healthcare because the experts are here,” said Perez-Tamayo. “I’m inviting healthcare professionals to join us to promote wellness across western Kansas. This movement will insure that patients receive high-quality care where they live. The collaborative effort makes primary doctors the captain of the team and they remain involved in all levels of care for patients.”

For more information or to register online for the Spring Health Symposium go to cccancer.com/symposium. Hotel discounts also are provided at the site, for those who will be attending the symposium from outside of the Garden City area. Those interested in learning more about the symposium also may contact Heartland Cancer Center Director Johanna Garzon, johanna.garzon@cccancer.com, 620-272-2579 ext. 347.

-30-

Illustration – Spring Health Symposium Banner

Central Care Cancer Center, https://www.cccancer.com


For more information, contact Johanna Garzon, Heartland Cancer Center, johanna.garzon@cccancer.com, 620-272-2579 ext. 347.

 March 5, 2018
FOR IMMEDIATE RELEASE

News release by: Michael Dawes, PR Manager – Central Care Cancer Center, 785-823-0633, ext. 228; michael.dawes@cccancer.com

Comments are closed.